SALT LAKE CITY, Aug. 4, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (NASDAQ:PRSN) has launched a software upgrade for its industry- leading energy ablation product MicroThermX, aimed at simplifying the customer interface and enhancing the user experience. The upgrade was made available to all MicroThermX systems in service on June 16th of this year.
The software upgrade to the MicroThermX system provides: a reduction in the number of screens, ability to seamlessly continue to the next procedure without requiring system restart, and a shortcut to tract coagulate from the procedure screen. Additionally, the update provides improved graphics, an improved logical display and streamlined information. These advancements combine to provide an enhanced customer experience.
"The software upgrade for the MicroThermX system is great news for physicians who use our technology to treat cancer, and the patients undergoing surgery. During surgical procedures, we believe the focus should be on the patient, not on controlling the equipment," said Clint E. Carnell, President and CEO of Perseon. "This news also serves to underscore Perseon's commitment to the development and constant improvement of energy ablation devices used to treat various forms of cancer."
The new system saves treatment time for the physicians and patients, and streamlines use when it counts – during surgery to treat soft tissue ablations. Unlike other products, the upgrade to MicroThermX requires minimal training and speeds up user navigation by reducing the overall interaction with the machine, as well as by matching the physician's workflow.
MicroThermX is a one-of-a-kind energy ablation system providing balance between precise treatment control, flexibility and power. Due to the flexibility of the system, physicians use MicroThermX in open, laparoscopic, and percutaneous surgical procedures. The system consists of a single generator and amplifier that deliver microwave energy to single or multiple antenna(s). The new software update serves to further improve the system.
About Perseon Corporation
Perseon Corporation, formerly BSD Medical Corporation, invests its resources in fighting humanity's worst disease – cancer. Perseon's team is dedicated to finding innovative technologies and aims to deliver energy ablation solutions to healthcare providers and patients around the world. MicroThermX treats soft tissue tumors with precision-focused energy, expanding the options and broadening the opportunities for cancer treatment.
Perseon's energy ablation system, MicroThermX, has been developed as a stand-alone therapy that employs precision-guided microwave energy to ablate (burn) and destroy soft tissue. Perseon has developed extensive intellectual property and has established distribution in the United States, Europe and Asia. Treatment sites include cancers of the liver, kidney, brain, bone, and lung.
Statements contained in this press release that are not historical facts, including statements relating to our focus on microwave ablation to create stockholder value and pursuit of our strategic plans are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties, including the risk that for a variety of reasons we may not be able to execute on our strategic plans, and other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date, except as required by law.
CONTACT: Jennifer R. Hoglin Vice President of Global Marketing Phone: (801) 972-5555 Email: email@example.com